Interventions for the treatment of persistent post-viral olfactory dysfunction

O'Byrne, Lisa, Webster, Katie E., MacKeith, Samuel, Philpott, Carl ORCID: https://orcid.org/0000-0002-1125-3236, Hopkins, Claire and Burton, Martin J. (2022) Interventions for the treatment of persistent post-viral olfactory dysfunction. Cochrane Database of Systematic Reviews, 2022 (2). ISSN 1465-1858

[thumbnail of OByrne_et_al-2022-Cochrane_Database_of_Systematic_Reviews] PDF (OByrne_et_al-2022-Cochrane_Database_of_Systematic_Reviews) - Published Version
Restricted to Repository staff only until 31 January 2023.

Request a copy

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects (benefits and harms) of interventions that have been used to treat post-viral olfactory dysfunction.

Item Type: Article
Additional Information: Funding Information: A number of COVID-19 studies have been funded by the National Institute for Health Research (NIHR) as part of its Recovery and Learning call, totalling ?5.5m in funding, to help better manage current and future waves of the COVID-19 pandemic and investigate its long-term impacts on the health and care system beyond the acute phase. This review is a companion project to two Cochrane living systematic reviews on the prevention and treatment of post COVID-19 olfactory dysfunction (O'Byrne 2021;?Webster 2021), which were funded by NIHR132103 - The prevention and treatment of persisting olfactory dysfunction following COVID-19 infection; a suite of Cochrane living systematic reviews. The aim of this review is to capture evidence on the management of general post-viral olfactory dysfunction, which may also inform the treatment of COVID-19 patients. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health and Social Care. Lisa O' Byrne, Evidence Synthesis Ireland Fellow,?was part-supported by the Health Research Board (Ireland) and the HSC Public Health Agency (Grant number CBES-2018-001) through Evidence Synthesis Ireland/Cochrane Ireland. The authors would like to acknowledge Lee Yee Chong for her work on generic methods content, some of which has been adapted for use in this review (with permission). We are grateful to Charn Gill and Lisha McClelland, University Hospitals Birmingham, for peer reviewing this protocol, and Elizabeth Stovold, Information Specialist with Cochrane Airways, for providing peer review comments on the draft search methods. Many thanks, lastly, to Professor Peter Tugwell for the editorial sign-off of this protocol. Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health and Social Care. Funding Information: Lisa O' Byrne, Evidence Synthesis Ireland Fellow, was part-supported by the Health Research Board (Ireland) and the HSC Public Health Agency (Grant number CBES-2018-001) through Evidence Synthesis Ireland/Cochrane Ireland. Publisher Copyright: Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Uncontrolled Keywords: pharmacology (medical) ,/dk/atira/pure/subjectarea/asjc/2700/2736
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 13 Apr 2022 10:30
Last Modified: 25 Oct 2022 13:31
URI: https://ueaeprints.uea.ac.uk/id/eprint/84619
DOI: 10.1002/14651858.CD014912

Actions (login required)

View Item View Item